LEVODOPA, CARBIDOPA, AND PYRIDOXINE IN PARKINSON DISEASE - METABOLIC INTERACTIONS

被引：25

作者：

MARS, H ^{[1
]}

机构：

[1] CASE WESTERN RESERVE UNIV,MT SINAI HOSP,DEPT NEUROL,DIV MED,CLEVELAND,OH 44106

来源：

关键词：

D O I：

10.1001/archneur.1974.00490360020005

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：444 / 447

页数：4

共 18 条

[1]

ANTON AH, 1962, J PHARMACOL EXP THER, V138, P360

[2]

COSTA E, 1972, ADV BIOCHEMICAL PSYC, V4

COTZIAS, GC ;

PAPAVASILIOU, PS .

[4]

DUVOISIN R C, 1969, Transactions of the American Neurological Association, V94, P81

EBADI, MS ;

RUSSELL, RL ;

MCCOY, EE .

[6]

EBADI MS, 1973, ADV BIOCHEMICAL PSYC, V4

[7]

EIDERSON S, 1972, ADV BIOCHEMICAL PSYC, V4

[8]

EVERED DF, 1971, LANCET, V1, P914

KURTZ, DJ ;

KANFER, JN .

LAVERTY, R ;

TAYLOR, KM .